Literature DB >> 16098867

Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicenter case series.

Edgardo Somigliana1, Anna Maria Bucceri, Cecilia Tibaldi, Salvatore Alberico, Marina Ravizza, Valeria Savasi, Silvia Marini, Roberta Matrone, Giorgio Pardi.   

Abstract

OBJECTIVE: Studies that mostly were conducted before the widespread use of combination antiretroviral treatments have reported that antenatal invasive procedures markedly increase the risk of human immunodeficiency virus vertical transmission. We aimed to evaluate the vertical transmission rate and other maternal and neonatal complications among women who were infected with human immunodeficiency virus who underwent antenatal invasive procedures during the second trimester of pregnancy and who were delivered after the advent of antiretroviral regimens. STUDY
DESIGN: We conducted a multicenter case series of women who were infected with human immunodeficiency virus who underwent amniocentesis or chorionic villus sampling or cordocentesis during the second trimester of pregnancy and who were delivered after January 1, 1997.
RESULTS: Sixty-three of 775 recruited women (8.1%) had performed early invasive diagnostic techniques . This rate has improved progressively from 4% in 1997 to 14%. Two of 60 viable infants (3.3%; 95% CI, 0.6%-10.1%) were infected with the human immunodeficiency virus. This rate did not differ significantly from the transmission rate that was observed in women who did not undergo antenatal invasive techniques (1.7%; P = .30).
CONCLUSION: The current risk of human immunodeficiency virus vertical transmission that is associated with early invasive diagnostic techniques is lower than previously reported.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098867     DOI: 10.1016/j.ajog.2004.12.087

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

Review 1.  Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement.

Authors:  Rachel Sagar; Graça Almeida-Porada; Karin Blakemore; Jerry K Y Chan; Mahesh Choolani; Cecilia Götherström; Agnes Jaulent; Tippi C MacKenzie; Citra Mattar; Christopher D Porada; William H Peranteau; Holm Schneider; Steven W Shaw; Simon N Waddington; Magnus Westgren; Anna L David
Journal:  Mol Ther       Date:  2020-10-16       Impact factor: 11.454

2.  Amniocentesis in the HIV-infected pregnant woman: Is there still cause for concern in the era of combination antiretroviral therapy?

Authors:  Nisha Andany; Michelle Letchumanan; Lise Bondy; Kellie Murphy; Mona R Loutfy
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

3.  Amniocentesis in HIV pregnant women: 16 years of experience.

Authors:  Mafalda Simões; Catarina Marques; Ana Gonçalves; Ana Paula Pereira; Joaquim Correia; João Castela; Cristina Guerreiro
Journal:  Infect Dis Obstet Gynecol       Date:  2013-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.